Security Snapshot

Korro Bio, Inc. - Common Stock, par value $0.001 per share (KRRO) Institutional Ownership

CUSIP: 500946108

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

75

Shares (Excl. Options)

11.59MFull value: 11,588,490 · shares · 30 Sep 2026

Price

$9.91

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-518,100
Value change
-$5,499,724
Number of holders
75
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
14,890,525
SEC-reported price per share
$12.02
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • KRRO - Korro Bio, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 500946108.
  • 75 institutions reported positions in Q3 2026.
  • 12 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 107 to 75 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $190.11MFull value: $190,106,005 · USD · 30 Jun 2026
    to
    $114.84MFull value: $114,840,072 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 75 institutions filings for Q3 2026.

Open SEC evidence

Security key

500946108

13F reference period

Q3 2026

13F holders

75

13D/G owners

12

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
12
Security
KRRO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynx1 Capital Management LP 11% +36% $18,351,871 +$9,599,630 1,538,296 +110% Lynx1 Capital Management LP 31 Mar 2026
Venrock Healthcare Capital Partners III, L.P. 9.9% 0% $17,719,427 -$174,566 1,474,162 -0.98% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2026
New Enterprise Associates 17, L.P. 9.9% $17,130,522 1,456,677 Ali Behbahani 10 Mar 2026
Adage Capital Management, L.P. 6.8% $8,810,000 1,000,000 Adage Capital Management, L.P. 30 Sep 2026
BALYASNY ASSET MANAGEMENT L.P. 5.9% -10% $7,658,806 -$726,402 869,331 -8.7% BALYASNY ASSET MANAGEMENT L.P. 30 Sep 2026
BlackRock, Inc. 4.9% -6% $7,113,814 -$294,666 717,813 -4% BlackRock, Inc. 30 Sep 2026
Atlas Venture Fund XI, L.P. 4.9% $10,287,455 706,556 Atlas Venture Fund XI, L.P. 24 Jun 2026
Nantahala Capital Management, LLC 6.4% $5,394,000 600,000 Nantahala Capital Management, LLC 31 Dec 2025
CITADEL ADVISORS LLC 3.9% $6,163,449 369,733 Citadel Advisors LLC 31 Dec 2024
Deep Track Capital, LP 3% $3,638,575 277,966 Deep Track Capital, LP 30 Jun 2025
FMR LLC 0.4% $303,227 37,857 FMR LLC 31 Dec 2025
ALLIANCEBERNSTEIN L.P. 0.1% -92% $100,793 -$9,138,050 7,700 -99% AllianceBernstein L.P. 30 Jun 2025
As of 30 Sep 2026, 75 institutional investors reported holding
11.59MFull value: 11,588,490 · shares · 30 Sep 2026
shares of Korro Bio, Inc. - Common Stock, par value $0.001 per share (KRRO). This represents 78% of the company’s total
14.89MFull value: 14,890,525 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
69%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Lynx1 Capital Management LP 10% 1,544,980 2.4% $15,310,752
NEA Management Company, LLC 8.7% 1,297,893 0.94% $12,862,120
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.7% 1,000,000 0.01% $9,910,000
Atlas Venture Life Science Advisors, LLC 5.2% 773,260 1.2% $7,663,007
Nantahala Capital Management, LLC 4.6% 680,246 0.38% $6,741,238
Affinity Asset Advisors, LLC 3.6% 531,904 0.3% $5,271,169
VANGUARD CAPITAL MANAGEMENT LLC 3.2% 477,626 0% $4,733,274
Kalehua Capital Management LLC 3.2% 473,595 3.5% $4,693,326
Driehaus Capital Management LLC 3% 450,045 0.03% $4,459,946
Venrock Adviser, LLC 3% 443,431 0.21% $4,394,401
TCG Crossover Management, LLC 2.8% 416,301 0.12% $4,125,543
Siren, L.L.C. 2.3% 347,718 0.08% $3,445,885
GEODE CAPITAL MANAGEMENT, LLC 1.9% 287,975 0% $2,854,138
72 Investment Holdings, LLC 1.9% 276,831 5% $2,743,395
STATE STREET CORP 1.6% 243,807 0% $2,416,127
VANGUARD PORTFOLIO MANAGEMENT LLC 1.5% 225,905 0% $2,238,719
TWO SIGMA INVESTMENTS, LP 1.1% 161,199 0% $1,597,482
GOLDMAN SACHS GROUP INC 0.72% 106,808 0% $1,058,467
Quantinno Capital Management LP 0.62% 91,733 0% $909,074
VANGUARD FIDUCIARY TRUST CO 0.5% 74,780 0% $741,070
Opaleye Management Inc. 0.47% 69,348 0.08% $687,239
RENAISSANCE TECHNOLOGIES LLC 0.44% 65,662 0% $650,710
EMERALD MUTUAL FUND ADVISERS TRUST 0.44% 65,442 0.03% $648,530
F/m Investments LLC 0.44% 65,442 0.02% $648,530
RAYMOND JAMES FINANCIAL INC 0.36% 53,109 0% $526,310

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
12
Headline period
Q3 2026
Rows shown
1-12 of 12
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 11,588,490 $114,840,072 -$5,499,724 $9.91 75
2026 Q2 14,424,412 $190,106,005 +$21,468,692 $13.18 107
2026 Q1 12,801,623 $144,841,768 +$60,140,705 $11.32 98
2025 Q4 7,561,789 $60,569,573 -$128,796,872 $8.01 82
2025 Q3 9,720,188 $465,499,291 +$39,225,055 $47.89 90
2025 Q2 8,912,049 $111,311,830 -$12,666,834 $12.49 68
2025 Q1 9,704,902 $168,963,706 -$381,515 $17.41 75
2024 Q4 9,447,026 $359,649,124 +$39,856,612 $38.07 83
2024 Q3 8,537,080 $285,308,897 -$12,430,500 $33.42 70
2024 Q2 8,435,947 $285,725,569 +$37,204,728 $33.87 63
2024 Q1 6,909,485 $618,593,997 +$31,054,435 $90.00 48
2023 Q4 5,491,489 $260,365,563 +$260,365,563 $47.93 38
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .